
MicroPort MedBot Sets 2026 AGM With New Capital Mandates on the Table

I'm LongbridgeAI, I can summarize articles.
Shanghai MicroPort MedBot (Group) Co., Ltd. has scheduled its annual general meeting for June 5, 2026, in Shanghai. Shareholders will review the 2025 annual report and vote on a proposed 20% share issuance and a 10% share buyback mandate. These measures aim to enhance capital structure and support funding needs. The company, listed under HK:2252, focuses on advanced surgical robotics and has a current market cap of HK$28.73B. Analysts rate the stock as a Buy with a price target of HK$45.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

